Routine Hemoglobin Blood Tests Linked to Long-Term Dementia Risk
Abnormally low or high hemoglobin levels in routine blood tests may indicate an increased long-term risk of developing dementia over a fifteen-year period, according to a large-scale study presented at the European College of Neuropsychopharmacology congress in Munich and published in the Journal of Alzheimer’s Disease. Researchers tracked 316,542 Korean adults aged 40 and older to examine how standard red blood cell measurements relate to future neurological health.
The study utilized national health screening data from 2004 and 2005, tracking participants through national health insurance records until the end of 2019. Investigators categorized participants into five distinct groups based on hemoglobin distribution, ranging from the lowest 20 percent to the highest 20 percent.
All-Cause Dementia Risk Rises at Both Ends of the Hemoglobin Spectrum
Participants with abnormally low hemoglobin levels showed a 16 percent higher risk of all-cause dementia compared to the others, while those with the highest hemoglobin levels faced a 7 percent increased risk. The data revealed that vulnerability profiles shifted depending on the specific type of dementia diagnosed over the monitoring period.
For Alzheimer’s disease, elevated risk concentrated primarily within the lowest 20 percent of hemoglobin levels, showing a 14 percent increase compared to control groups. Participants with low hemoglobin levels faced a 19 percent higher risk of vascular dementia—caused by reduced cerebral blood flow—while those with very high levels experienced an 18 percent increased risk. However, for vascular dementia, the relationship was not linear for the five hemoglobin groups. The association was also clearer and more consistent in women than in men,
the authors stated in a release.
Researchers Caution Against Direct Supplementation to Prevent Brain Decline
Study authors emphasized that abnormal hemoglobin acts as a visible marker of broader physical vulnerability rather than a direct biological cause of dementia. Lead author Dr. Hyun Soo Kim, assistant professor at Dong-A University College of Medicine in Busan, South Korea, stated that an abnormal result should prompt a conversation with a physician regarding underlying health issues rather than self-treatment.
Dr. Kim specifically warned against taking iron supplements or attempting to artificially manipulate hemoglobin levels solely to prevent brain decline, concluding that an abnormal hemoglobin result should rather be discussed with a doctor, as it may reveal underlying health problems requiring special attention.
Clinicians view the marker’s primary utility in its accessibility, as hemoglobin testing remains inexpensive, familiar, and already integrated into standard medical evaluations worldwide.
Frequently Asked Questions About Hemoglobin and Brain Health
What biological function does hemoglobin serve in the human body?
Hemoglobin is the protein in red blood cells that transports oxygen throughout the body. Low levels are typically associated with anemia, whereas elevated levels can reflect factors such as smoking, dehydration, heart or lung disease, or other medical issues.
Does this study prove that correcting abnormal hemoglobin prevents dementia?
No, the research does not demonstrate a causal relationship or prove that altering hemoglobin levels will prevent cognitive decline. Investigators stressed that abnormal readings serve as an accessible indicator of physical vulnerability that warrants clinical evaluation rather than direct intervention.
How did researchers track dementia diagnoses over fifteen years?
Scientists analyzed national health screening records gathered in South Korea during 2004 and 2005, cross-referencing national health insurance databases to track new clinical diagnoses of dementia up through the end of 2019.
Related reading